Zobrazeno 1 - 10
of 69
pro vyhledávání: '"Darrell O. Ricke"'
Autor:
Darrell O. Ricke
Publikováno v:
Exploration of Neuroscience, Vol 3, Iss 5, Pp 508-519 (2024)
Aim: Seizure and epilepsy adverse events (AEs) can occur following vaccination. For epilepsy AEs, they are generally expected to only occur at background population frequencies without associations with immunizations. The Vaccine AEs Reporting System
Externí odkaz:
https://doaj.org/article/29c63cd5acfc43d69e7a26e6f91f7da5
Autor:
Darrell O. Ricke, Nora Smith
Publikováno v:
Life, Vol 14, Iss 3, p 353 (2024)
Background: Vasculitis diseases include Kawasaki disease (KD), Kawasaki disease shock syndrome (KDSS), Multisystem Inflammatory Syndrome (MIS), Henoch–Schönlein purpura (HS), or IgA vasculitis, and additional vasculitis diseases. These diseases ar
Externí odkaz:
https://doaj.org/article/d9020c030d0c4d9d87d564ba38bad635
Publikováno v:
International Journal of Infectious Diseases, Vol 113, Iss , Pp 331-335 (2021)
Objectives: The clinical manifestations of COVID-19 associated cardiac complications are heterogeneous, ranging from asymptomatic to severe symptoms, including arrhythmias and cardiogenic shock. For COVID-19 patients with cardiac sequela, only a smal
Externí odkaz:
https://doaj.org/article/034152e77fb645f7bd8dde937488b550
Autor:
Darrell O. Ricke
Publikováno v:
JID Innovations, Vol 1, Iss 4, Pp 100052- (2021)
Externí odkaz:
https://doaj.org/article/e1ed6e81c5774085a4f8799b1ab1b226
Autor:
Robert W. Malone, Philip Tisdall, Philip Fremont-Smith, Yongfeng Liu, Xi-Ping Huang, Kris M. White, Lisa Miorin, Elena Moreno, Assaf Alon, Elise Delaforge, Christopher D. Hennecker, Guanyu Wang, Joshua Pottel, Robert V. Blair, Chad J. Roy, Nora Smith, Julie M. Hall, Kevin M Tomera, Gideon Shapiro, Anthony Mittermaier, Andrew C. Kruse, Adolfo García-Sastre, Bryan L. Roth, Jill Glasspool-Malone, Darrell O. Ricke
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
SARS-CoV-2 infection is required for COVID-19, but many signs and symptoms of COVID-19 differ from common acute viral diseases. SARS-CoV-2 infection is necessary but not sufficient for development of clinical COVID-19 disease. Currently, there are no
Externí odkaz:
https://doaj.org/article/886e5d63bd85412f90473f81dc54eb9e
Autor:
Darrell O. Ricke
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
COVID-19 (SARS-CoV-2) disease severity and stages varies from asymptomatic, mild flu-like symptoms, moderate, severe, critical, and chronic disease. COVID-19 disease progression include lymphopenia, elevated proinflammatory cytokines and chemokines,
Externí odkaz:
https://doaj.org/article/7ab48d7fd09048339059f39ec8498979
Autor:
Nicholas G. Kounis, Ioanna Koniari, Cesare de Gregorio, Stelios F. Assimakopoulos, Dimitrios Velissaris, Ming-Yow Hung, Virginia Mplani, Luca Saba, Aikaterini Brinia, Sophia N. Kouni, Christos Gogos, Mattia Giovannini, Elio Novembre, Vinu Arumugham, Darrell O. Ricke, George D. Soufras, Kenneth Nugent, Piero Sestili, Robert W. Malone
Publikováno v:
Biomedicines, Vol 9, Iss 8, p 959 (2021)
Coronavirus disease 2019 (COVID-19) and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) constitute one of the deadliest pandemics in modern history demonstrating cardiovascular, gastrointestinal, hematologic, mucocutaneous, respiratory,
Externí odkaz:
https://doaj.org/article/2fce87cbe6a6429bbb22f212cbe4490f
Autor:
Kelly A. Meiklejohn, Melissa K. R. Scheible, Laura M. Boggs, Robert R. Dunn, Darrell O. Ricke
Publikováno v:
Journal of Forensic Sciences. 68:768-779
Autor:
Darrell O. Ricke
Publikováno v:
AIMS Allergy and Immunology. 7:164-175
Some individuals experience dizziness, syncope (temporary loss of consciousness caused by a fall in blood pressure), seizure, and similar rare adverse events after vaccination. Sudden impacts to alertness, consciousness, ability to talk, vision, or b
Autor:
Darrell O Ricke
Publikováno v:
Journal of Modern Biology and Drug Discovery.
Objective: A placebo is by definition a harmless substance with no therapeutic effect. Clinical studies often include placebo controls to enable differentiation between treatment efficacy and adverse events from placebo effects. Intramuscular injecti